Mackenzie Financial
GOSS icon

Mackenzie Financial’s Gossamer Bio GOSS Stock Holding History

Mackenzie Financial’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,536,923
Closed -$505K – 1613
2026
Q1 		$505K Buy
1,536,923
+1,230,470
+402% +$1.93M ﹤0.01% 1211
2025
Q4 		$954K Sell
306,453
-2,597
-0.8% -$7.41K ﹤0.01% 1072
2025
Q3 		$813K Sell
309,050
-244,014
-44% -$538K ﹤0.01% 1119
2025
Q2 		$680K Buy
553,064
+200,591
+57% +$219K ﹤0.01% 1120
2025
Q1 		$388K Buy
352,473
+52,658
+18% +$60.9K ﹤0.01% 1288
2024
Q4 		$271K Buy
299,815
+249,765
+499% +$214K ﹤0.01% 1428
2024
Q3 		$49.4K Buy
+50,050
New +$48.1K ﹤0.01% 1537

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Mackenzie Financial's GOSS Position: Q2 2026 in Review

Mackenzie Financial sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 1,536,923 shares — an estimated $505K sold.

Mackenzie Financial first reported a position in GOSS in Q3 2024 and held it in 7 quarters. The position peaked at $954K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Mackenzie Financial reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Mackenzie Financial sold 1,536,923 Gossamer Bio shares in Q2 2026, an estimated $505K.
  • Mackenzie Financial first reported a position in Gossamer Bio in Q3 2024 and held it in 7 quarters.
  • Mackenzie Financial's Gossamer Bio position peaked at $954K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.